Search Results 3681-3690 of 36727 for oral

1. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

2. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

3. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

   Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...

4. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

   ... Oral biopsy, Microvascular surgery, Facial reconstruction, Skull base surgery, Glossectomy, Tracheostomy, Skin cancer reconstruction, Submandibular gland ...

5. Accelerating Gastrointestinal Recovery - Clinical Trials

   This study is designed to determine whether an oral perioperative medication (alvimopan--a selective mu antagonist) improves bowel recovery over placebo after ...

6. Mother's Day Has Special Meaning After Stroke and Heart Surgery - Mayo Clinic News Network

   As a result, Ashley had to take a daily oral dose of the blood-thinning medication Coumadin to prevent the formation of blood clots and reduce the risk of ...

7. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

8. A Study To Evaluate KIN-2787 In Participants With BRAF And/or NRAS Mutation Positive Solid Tumors - Mayo Clinic

   * Able to swallow, retain, and absorb oral medications. Exclusion Criteria ... * GI tract disease causing an inability to take oral medication ...

9. Study To Evaluate The Safety, Tolerability & Efficacy Of TNG462 In Combination In PDAC & NSCLC Patients - Mayo Clinic

   ... oral TNG462 in combination with RMC-6236 or RMC-9805. The study comprises a ... oral medications 8. Has known or suspected active or untreated CNS ...

10. A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease - Mayo Clinic

    * Any ongoing treatment with systemic immunosuppressants, systemic corticosteroids, or use of oral budesonide in the 12 weeks before screening. * Ongoing ...